Metraipolis › archive › dc_c08cac44d809

Considering late effects costs in radiotherapy funding — Europe PMC PMID:41121464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41121464
DOI
10.1093/bjr/tqaf254
License (as archived)
solo-consultazione
Archived
2026-11-08T03:13:26.054Z
SHA-256 of the archived text
1fdeadef40777b59af17a514242140e448ed2bcfbf5fe288541fb630dcd1c72f
Stable URL of this page
https://metraipolis.com/documento/dc_c08cac44d809

How to cite

Considering late effects costs in radiotherapy funding — Europe PMC PMID:41121464 — Europe PMC (en), https://europepmc.org/article/MED/41121464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c08cac44d809 (Metraipolis archive dc_c08cac44d809, sha256 1fdeadef40777b59af17a514242140e448ed2bcfbf5fe288541fb630dcd1c72f)
BibTeX
@misc{dcc08cac44d809,
  title = {Considering late effects costs in radiotherapy funding — Europe PMC PMID:41121464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41121464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c08cac44d809; sha256 1fdeadef40777b59af17a514242140e448ed2bcfbf5fe288541fb630dcd1c72f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41121464. Agents can read the archived copy with the MCP tool read_document.